ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,132Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 41

$712K Total Retail Price of All Prescriptions

Rank: 6 out of 41

474 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 474 patients filled at least one prescription for a schedule two drug, compared to an average of 11%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 11,115 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
LEVOTHYROXINE SODIUM 602 565 1 4
OMEPRAZOLE 443 427 2 2
DONEPEZIL HCL 439 431 3 13
FUROSEMIDE 431 392 4 5
LISINOPRIL 408 378 5 1
WARFARIN SODIUM 368 360 6 6
NAMENDA 327 316 7 30
CITALOPRAM HBR 317 296 8 8
SIMVASTATIN 313 312 9 3
AMLODIPINE BESYLATE 255 241 10 9
GABAPENTIN 250 246 11 11
ATENOLOL 240 234 12 10
MIRTAZAPINE 216 215 13 15
METOPROLOL TARTRATE 211 210 14 7
TRAZODONE HCL 209 191 15 14
SERTRALINE HCL 193 188 16 17
QUETIAPINE FUMARATE 189 172 17 21
JANTOVEN 178 176 18 24
METOPROLOL SUCCINATE 168 165 19 16
POLYETHYLENE GLYCOL 3350 166 164 20 22
TAMSULOSIN HCL 124 123 21 32
LIDODERM 124 122 21 47
LANTUS 117 101 23 25
IPRATROPIUM-ALBUTEROL 111 104 24 48
POTASSIUM CHLORIDE 109 106 25 20
ALENDRONATE SODIUM 106 105 26 29
LOSARTAN POTASSIUM 102 102 27 23
TAMIFLU 101 96 28 55
FLUTICASONE PROPIONATE 100 93 29 50
CARVEDILOL 92 78 30 41
METFORMIN HCL 91 67 31 19
TRAMADOL HCL 89 89 32 18
OLANZAPINE 87 57 33 28
HUMALOG 87 77 33 107
PREDNISONE 86 68 35 27
RISPERIDONE 82 74 36 31
TRIAMTERENE-HCTZ 79 68 37 65
SPIRONOLACTONE 72 71 38 72
HYDROCHLOROTHIAZIDE 70 70 39 12
SEROQUEL 68 63 40 52
NOVOLOG 68 64 40 42
FLUOXETINE HCL 65 40 42 59
NYSTOP 65 55 42 45
KLOR-CON M20 62 48 44 49
ADVAIR DISKUS 57 49 45 57
GLIPIZIDE 57 54 45 53
PRAVASTATIN SODIUM 55 55 47 78
SPIRIVA 55 55 47 58
ESCITALOPRAM OXALATE 55 54 47 80
DIVALPROEX SODIUM 54 53 50 35
DIOVAN 53 53 51 82
CARBIDOPA-LEVODOPA 51 51 52 36
NYSTATIN 50 47 53 54
BACLOFEN 50 36 53 66
KLOR-CON M10 50 50 53 76
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 15, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.